Cystic fibrosis mutation analysis: How many is enough? [2]

Genetics in Medicine

Volumn 6, Issue 5, 2004, Pages 456-458

  Tsongalis, Gregory J ^a   Belloni, Dorothy R ^a   Grody, Wayne W ^b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAUCASIAN; CFTR GENE; CYSTIC FIBROSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ETHNIC DIFFERENCE; GENE FREQUENCY; GENE MUTATION; GENETIC COUNSELING; GENETIC IDENTIFICATION; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH ECONOMICS; HUMAN; INCIDENCE; LETTER; MASS SCREENING; MUTATIONAL ANALYSIS; RACE DIFFERENCE; RARE DISEASE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; UNITED STATES;

CYSTIC FIBROSIS; DNA MUTATIONAL ANALYSIS; HUMANS;

EID: 4644311396     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GIM.0000139542.56994.67     Document Type: Letter

References (15)

1. Lewis MJ, Lewis EH 3rd, Amos JA, Tsongalis GJ. Cystic Fibrosis. Am J Clin Pathol 2003;120(Suppl 1):S3-S13.
2. Hamosh A, Fitzsimmons SC, Macek M, Knowles MR, Rosenstein BJ, Cutting GR. Comparison of the clinical manifestations of cystic fibrosis in black and white patients. J Pediatr 1998;132:255-259.
3. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC. Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245:1073-1080.
4. Consortium., T. C. F. G. A. Cystic Fibrosis Mutation Data Base. Accessed 2004, http://www.genet.sickkids.on.ca/cftr/.
5. Grody WW, Desnick RJ, Carpenter NJ, Noll WW. Diversity of cystic fibrosis mutation screening practice. Am J Hum Genet 1998;62:1252-1254.
6. Eng CM, Schechter C, Robinowitz J, Fulop G, Burden T, Levy B, Zinberg R, Desnick RJ. Prenatal genetic carrier testing using triple disease screening. JAMA 1997;278:1268-1272.
7. NIH Consensus Conference on Genetic Testing for CF. Arch Int Med 1997;159:1529-1539.
8. Grody WW, Cutting GR, Klinger KW, Richards CS, Watson MS, Desnick RJ. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 2001;3:149-154.
9. ACOG. Preconception and prenatal carrier screening for cystic fibrosis: clinical laboratory guidelines. American College of Obstetricians and Gynecologists, Washington, D.C. 2001;1-31.
10. Watson MS, Desnick RJ, Grody WW, Mennuti MT, Popovich BW, Richards CS. Cystic fibrosis carrier screening: issues in implementation. Genet Med 2002;4:407-409.
11. Gilbert F. Cystic fibrosis carrier screening: steps in the development of a mutation panel. Genet Test 2001;5:223-227.
12. Heim RA, Sugarman EA, Allitto BA. Improved detection of cystic fibrosis mutations in the herterozygous U.S. population using an expanded, pan-thnic mutation panel. Genet Med 2001;3(3):168-176.
13. Watson MS, Cutting GR, Desnick RJ, Driscoll DA, Klinger K, Mennuti M, Palomaki GE, Popovich BW, Pratt VM, Rohlfs E, Stom CM, Richards CS, Witt DR, Grody WW. Cystic fibrosis couple carrier screening: 2004 revision of ACMG's mutation panel. Genet Med 2004;6:387-391.
14. Rohlfs EM, Zhou Z, Sugarman EA, Heim RA, Pace RG, Knowles MR, Silverman LM, Allitto BA. The I148T CFTR allele occurs on multiple haplotypes: a complex allele is associated with cystic fibrosis. Genet Med 2002;4:319-323.
15. Buller A, Olson S, Redman JB, Hantash F, Chen R, Strom CM. Frequency of the cystic fibrosis 3199del6 mutation in individuals heterozygous for I148T. Genet Med 2004;6:108-109.